Search by CAS No , Chemical Name or Molecular Formula
"Hydralazine, sold under the brand name Apresoline among others, is a medication used to treat high blood pressure and heart failure. This includes high blood pressure in pregnancy and very high blood pressure resulting in symptoms. It has been found to be particularly useful in heart failure together with isosorbide dinitrate in black people. It is given by mouth or by injection into a vein. Effects usually begin around 15 minutes and last up to six hours.
Common side effects include headache and fast heart rate. It is not recommended in people with coronary artery disease or rheumatic heart disease that is affecting the mitral valve. In those with kidney problems a low dose is recommended. Hydralazine is in the vasodilator family of medications and is believed to work by causing the dilation of blood vessels.
Hydralazine was discovered while scientists at Ciba were looking for a treatment for malaria. It was patented in 1949. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is about 2.78 to 9.11 USD per month. In the United States treatment costs about 50 to 100 USD per month.",""
Labeled Hydralazine, intended for use as an internal standard for the quantification of Hydralazine by GC- or LC-mass spectrometry.
We normally respond within 8 hours.
This page contains information about Hydralazine 15N4 Cas # 1346747-08-7 and its Stable Isotopes.
Hydralazine 15N4 Hydralazine 15N4 Worldwide Suppliers of Hydralazine 15N4 https://www.clearsynth.com/en/CSO16069.html Stable Isotopes Clearsynth 1346747-08-7
Product rating: 9 Hydralazine 15N4 based on 20 ratings
Keywords: Stable Isotopes 1-[(1,2-15N2)hydrazin-1-yl](2,3-15N2)phthalazine CS-O-16069 Hydralazine 15N4 Hydralazine 1346747-08-7 164.15 C8H8[15N]4
Internal standard, Internal standard Hydralazine, HPLC-MS method validation, HPLC-MS method validation Hydralazine, LC-MS-MS method validation, LC-MS-MS method validation Hydralazine, Deuterated internal standard, Deuterated internal standard Hydralazine, Deuterated Hydralazine, Deuterium labeled Hydralazine, Quantitative bioanalytical methods, Quantitative bioanalytical methods Hydralazine, Blood samples Hydralazine, Blood concentrations, Heavy drugs, Analysis, Analysis Hydralazine, Clinical diagnostic, Clinical diagnostic Hydralazine, Dosing Hydralazine, Analytical method development, Internal standard method.
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
T : +91-40-27155481
CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
T : +91-22-45045945